Punch & Associates Investment Management’s Phibro Animal Health PAHC Stock Holding History

Punch & Associates Investment Management’s Portfolio PAHC Stock Details PAHC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-222,122	Closed	-$2.95M	–	231
2022 Q3	$2.95M	Sell	222,122 -178,992	-45%	-$3.09M	0.21%	140
2022 Q2	$7.67M	Buy	401,114 +8,770	+2%	+$166K	0.54%	81
2022 Q1	$7.83M	Buy	392,344 +15,006	+4%	+$303K	0.44%	101
2021 Q4	$7.71M	Buy	377,338 +5,589	+2%	+$119K	0.4%	103
2021 Q3	$8.01M	Buy	371,749 +3,675	+1%	+$88.5K	0.46%	92
2021 Q2	$10.6M	Buy	368,074 +3,155	+0.9%	+$85.3K	0.6%	56
2021 Q1	$8.9M	Buy	364,919 +17,848	+5%	+$403K	0.53%	76
2020 Q4	$6.74M	Buy	347,071 +156,163	+82%	+$2.87M	0.47%	92
2020 Q3	$3.32M	Sell	190,908 -513	-0.3%	-$10.9K	0.29%	132
2020 Q2	$5.03M	Buy	+191,421	New	+$4.75M	0.46%	90

Other funds holding PAHC

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Pzena Investment Management New York $30.8B AUM 11.29% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Heartland Advisors Milwaukee, Wisconsin $1.96B AUM 28.26% 1-Year Est. Return

BIP

Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

SGCIA

Smith Graham & Co Investment Advisors Houston, Texas $868M AUM 24.69% 1-Year Est. Return

Punch & Associates Investment Management's PAHC Position: Q4 2022 in Review

Punch & Associates Investment Management sold out of Phibro Animal Health (PAHC) in Q4 2022, closing a stake of 222,122 shares — an estimated $2.95M sold.

Punch & Associates Investment Management first reported a position in PAHC in Q2 2020 and held it in 10 quarters. The position peaked at $10.6M in Q2 2021. 132 funds tracked by Wall St. Rank hold PAHC as of Q4 2022.

Punch & Associates Investment Management reported no remaining Phibro Animal Health position as of Q4 2022 after selling out during the quarter.
Punch & Associates Investment Management sold 222,122 Phibro Animal Health shares in Q4 2022, an estimated $2.95M.
Punch & Associates Investment Management first reported a position in Phibro Animal Health in Q2 2020 and held it in 10 quarters.
Punch & Associates Investment Management's Phibro Animal Health position peaked at $10.6M in Q2 2021.
132 funds tracked by Wall St. Rank held Phibro Animal Health as of Q4 2022.

Based on Punch & Associates Investment Management's 13F filing for Q4 2022, filed 14 Feb 2023.